Tycho Jan Zuzak
Research Subjects
Tycho Jan Zuzak has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Alfred Längler
7 shared publicationsMelanie Schwermer
Abteilung für pädiatrische Onkologie und Hämatologie Universitäts Kinderklinik Essen, Essen, Deutschland
6 shared publicationsAlexander Schramm
Medizinische Onkologie, Westdeutsches Tumorzentrum, Universitätskrankenhaus Essen, Universität Duisburg-Essen, Essen, Deutschland
5 shared publicationsKatrin Menke
Abteilung für pädiatrische Onkologie und Hämatologie Universitäts Kinderklinik Essen, Essen, Deutschland
5 shared publications- Alfred Längler
Department of Paediatrics, Gemeinschaftskrankenhaus, Herdecke, Germany
4 shared publications - Melanie Schwermer
Gemeinschaftskrankenhaus Herdecke, Dept Pediat, Herdecke, Germany
3 shared publications
Latest Publications
- 15 January 2026
- Published by Springer Nature
- p. 681-694
Integrative Pädiatrie
- Open Access
Vegetarian Diet and Dietary Intake, Health, and Nutritional Status in Infants, Children, and Adolescents: A Systematic Review
Background/Objectives: More children and adolescents are adopting vegetarian diets. A balanced diet is particularly important for growth and bone development in children. It is important to clarify whether a vegetarian diet affects these processes. A systematic literature review was conducted to identify studies investigating differences in anthropometric data, nutrient intake, and biomarkers between vegetarian and omnivorous children. Methods: PUBMED, MEDLINE, and Web of Science Core Collections were searched between the end of 2014 and 2023. We included peer-reviewed randomized controlled trials, intervention, or observational studies that were published in English or German and investigated the differences between healthy children and adolescents from high-income countries who consumed either a vegetarian or an omnivorous diet. The review was conducted in accordance with the PRISMA guidelines. If at least five values with the same unit were available from different studies, a cumulative analysis of selected parameters was conducted. Due to the participants’ varying ages across the studies, limited cumulative analyses were conducted additionally by age category. Results: A total of 1681 studies were screened, of which 20 met the inclusion criteria. Significant differences were found in fiber and energy intake from carbohydrates and proteins. The results were strengthened by the restricted cumulative analysis of the 2–10 age category, which also revealed significant differences when comparing VG and OM. Conclusions: A higher intake of fiber, more energy from carbohydrates, and sufficient energy from proteins and less from fat can be regarded as the benefits of a vegetarian diet, according to this review. There are also the first indications of enhanced vitamin C and E, iron, folate, and magnesium intake. These characteristics can be regarded as potential benefits of a vegetarian diet. A lower vitamin B12 and vitamin D intake has been identified as a potential risk factor. Further longitudinal, prospective, observational studies are needed. Prospero registration date and number: 6 March 2023, CRD42023402301.
Open AccessVegetarian Diet and Dietary Intake, Health, and Nutritional Status in Infants, Children, and Adolescents: A Systematic Review
Background/Objectives: More children and adolescents are adopting vegetarian diets. A balanced diet is particularly important for growth and bone development in children. It is important to clarify whether a vegetarian diet affects these processes. A systematic literature review was conducted to identify studies investigating differences in anthropometric data, nutrient intake, and biomarkers between vegetarian and omnivorous children. Methods: PUBMED, MEDLINE, and Web of Science Core Collections were searched between the end of 2014 and 2023. We included peer-reviewed randomized controlled trials, intervention, or observational studies that were published in English or German and investigated the differences between healthy children and adolescents from high-income countries who consumed either a vegetarian or an omnivorous diet. The review was conducted in accordance with the PRISMA guidelines. If at least five values with the same unit were available from different studies, a cumulative analysis of selected parameters was conducted. Due to the participants’ varying ages across the studies, limited cumulative analyses were conducted additionally by age category. Results: A total of 1681 studies were screened, of which 20 met the inclusion criteria. Significant differences were found in fiber and energy intake from carbohydrates and proteins. The results were strengthened by the restricted cumulative analysis of the 2–10 age category, which also revealed significant differences when comparing VG and OM. Conclusions: A higher intake of fiber, more energy from carbohydrates, and sufficient energy from proteins and less from fat can be regarded as the benefits of a vegetarian diet, according to this review. There are also the first indications of enhanced vitamin C and E, iron, folate, and magnesium intake. These characteristics can be regarded as potential benefits of a vegetarian diet. A lower vitamin B12 and vitamin D intake has been identified as a potential risk factor. Further longitudinal, prospective, observational studies are needed. Prospero registration date and number: 6 March 2023, CRD42023402301.
- Open Access
- 16 August 2022
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 8 (1) , 1-10
Warming up for a better fever: a randomized pilot study in pediatric oncology
Background: Fever in children is a major problem in pediatric oncology. Usual management leads to immediate antibiotic and antipyretic therapy, although there is consensus that antipyretic therapy should not be utilized with the sole aim of reducing body temperature. Increased body temperature during fever appears to be an effective modifier in terms of viral replication and enhanced host defense mechanisms against pathogens. Therefore, it might be beneficial to support febrile patients by applying gentle heat during the onset of fever to help the body to reach its new thermoregulatory set point.Methods: A randomized pilot study over 6 months will be conducted in a pediatric oncology department in an academic hospital in Germany. This study is a preparation for a multicenter clinical trial with two parallel groups concerning the efficacy of heat application vs. treatment as usual. One of the inclusion criteria is body temperatures ≥ 38.0 °C inn= 24 cases of patients receiving chemotherapy aged 18 months to 17 years. The first intervention consists of gentle heat application with hot water bottles at any sign of illness and onset of fever. The aim is to achieve a warm periphery equilibrated to trunk temperature of less than 0.5 °C. The second intervention is the avoidance of antipyretics. The control group receives the standard antipyretic treatment from the participating hospital. The purposes of this pilot study are proof of principle of intervention, evaluation of safety, feasibility, definition of endpoints, and to receive basic data for sample size calculation and needed resources.Discussion: The main goal is to improve the care of children with cancer by providing the best possible support for febrile episodes. If fever support by heat reduces discomfort, administration of antipyretics and maybe even antibiotics, this would be an advancement in oncological fever management. This pilot study is intended to provide a basis for a main, multicenter, randomized trial and demonstrate the practicability of heat application in febrile patients in pediatric oncology.Trial registration: German Clinical Trials Register (DRKS),DRKS00028273. Registered on 14 April 2022
- 16 August 2022
- Published by Springer Nature in Pilot and Feasibility Studies
- Vol. 8 (1) , 1-10
Open AccessWarming up for a better fever: a randomized pilot study in pediatric oncology
Background: Fever in children is a major problem in pediatric oncology. Usual management leads to immediate antibiotic and antipyretic therapy, although there is consensus that antipyretic therapy should not be utilized with the sole aim of reducing body temperature. Increased body temperature during fever appears to be an effective modifier in terms of viral replication and enhanced host defense mechanisms against pathogens. Therefore, it might be beneficial to support febrile patients by applying gentle heat during the onset of fever to help the body to reach its new thermoregulatory set point.Methods: A randomized pilot study over 6 months will be conducted in a pediatric oncology department in an academic hospital in Germany. This study is a preparation for a multicenter clinical trial with two parallel groups concerning the efficacy of heat application vs. treatment as usual. One of the inclusion criteria is body temperatures ≥ 38.0 °C inn= 24 cases of patients receiving chemotherapy aged 18 months to 17 years. The first intervention consists of gentle heat application with hot water bottles at any sign of illness and onset of fever. The aim is to achieve a warm periphery equilibrated to trunk temperature of less than 0.5 °C. The second intervention is the avoidance of antipyretics. The control group receives the standard antipyretic treatment from the participating hospital. The purposes of this pilot study are proof of principle of intervention, evaluation of safety, feasibility, definition of endpoints, and to receive basic data for sample size calculation and needed resources.Discussion: The main goal is to improve the care of children with cancer by providing the best possible support for febrile episodes. If fever support by heat reduces discomfort, administration of antipyretics and maybe even antibiotics, this would be an advancement in oncological fever management. This pilot study is intended to provide a basis for a main, multicenter, randomized trial and demonstrate the practicability of heat application in febrile patients in pediatric oncology.Trial registration: German Clinical Trials Register (DRKS),DRKS00028273. Registered on 14 April 2022
- 23 February 2021
- Published by S. Karger AG in Complementary Medicine Research
- Vol. 28 (4) , 308-316
Präklinische Untersuchungen von Wechselwirkungen zwischen Mistel und Radio- oder Chemotherapie auf pädiatrische Tumorzellen
Hintergrund: Mistelanwendungen werden als komplementäre Therapien häufig in der pädiatrischen Onkologie zusammen mit einer Radio- oder Chemotherapie verabreicht. Wechselwirkungen bei simultaner Applikation sind gerade in der Pädiatrie von großer Bedeutung, sie sind allerdings nach wie vor unzureichend untersucht. Material und Methoden: Zytotoxische Effekte des Mistelextraktes abnobaVISCUM Fraxini (aVF) auf LAN-1 Neuroblastomzellen und deren Etoposid- bzw. Cisplatin-resistente Subzelllinien wurden mittels Viabilitätstest untersucht, sowie mögliche Synergieeffekte zwischen aVF und den Chemotherapeutika durch die Softwareprodukte Combenefit und CompuSyn analysiert. Effekte einer Kombinationstherapie aus aVF und Bestrahlung auf SH-SY5Y Zellen wurden mittels Koloniebildungstest untersucht und Auswirkungen auf die Reparatureffizienz strahleninduzierter Doppelstrangbrüche mit Hilfe durchflusszytometrischer Quantifizierungen von γ-H2AX-Foci nach PI/FITC Doppelfärbung analysiert. Ergebnisse: Die Chemotherapie-resistenten LAN-1 Subzelllinien erwiesen sich als resistenter gegenüber der Mistelbehandlung als die Ursprungszelllinie. Auf Basis vier verschiedener Referenzmodelle konnten vor allem synergistisch/additive Effekte zwischen aVF und den Zytostatika Etoposid und Cisplatin berechnet werden. Die Kombination aus Mistelbehandlung und Bestrahlung führte zu einer Verringerung der Koloniebildung und zu einer Verzögerung der Reparaturgeschwindigkeit von strahleninduzierten Doppelstrangbrüchen. Schlussfolgerung: Die präklinischen Daten könnten darauf hinweisen, dass die Verwendung des Mistelextraktes, aVF, eine unterstützende Wirkung auf Radio- und Chemotherapien hat.
- 23 February 2021
- Published by S. Karger AG in Complementary Medicine Research
- Vol. 28 (4) , 308-316
Präklinische Untersuchungen von Wechselwirkungen zwischen Mistel und Radio- oder Chemotherapie auf pädiatrische Tumorzellen
Hintergrund: Mistelanwendungen werden als komplementäre Therapien häufig in der pädiatrischen Onkologie zusammen mit einer Radio- oder Chemotherapie verabreicht. Wechselwirkungen bei simultaner Applikation sind gerade in der Pädiatrie von großer Bedeutung, sie sind allerdings nach wie vor unzureichend untersucht. Material und Methoden: Zytotoxische Effekte des Mistelextraktes abnobaVISCUM Fraxini (aVF) auf LAN-1 Neuroblastomzellen und deren Etoposid- bzw. Cisplatin-resistente Subzelllinien wurden mittels Viabilitätstest untersucht, sowie mögliche Synergieeffekte zwischen aVF und den Chemotherapeutika durch die Softwareprodukte Combenefit und CompuSyn analysiert. Effekte einer Kombinationstherapie aus aVF und Bestrahlung auf SH-SY5Y Zellen wurden mittels Koloniebildungstest untersucht und Auswirkungen auf die Reparatureffizienz strahleninduzierter Doppelstrangbrüche mit Hilfe durchflusszytometrischer Quantifizierungen von γ-H2AX-Foci nach PI/FITC Doppelfärbung analysiert. Ergebnisse: Die Chemotherapie-resistenten LAN-1 Subzelllinien erwiesen sich als resistenter gegenüber der Mistelbehandlung als die Ursprungszelllinie. Auf Basis vier verschiedener Referenzmodelle konnten vor allem synergistisch/additive Effekte zwischen aVF und den Zytostatika Etoposid und Cisplatin berechnet werden. Die Kombination aus Mistelbehandlung und Bestrahlung führte zu einer Verringerung der Koloniebildung und zu einer Verzögerung der Reparaturgeschwindigkeit von strahleninduzierten Doppelstrangbrüchen. Schlussfolgerung: Die präklinischen Daten könnten darauf hinweisen, dass die Verwendung des Mistelextraktes, aVF, eine unterstützende Wirkung auf Radio- und Chemotherapien hat.
- 1 August 2020
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 52, 102493
Complementary, alternative, integrative and dietary therapies for children with Crohn’s disease – A systematic review
- 1 August 2020
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 52, 102493
Complementary, alternative, integrative and dietary therapies for children with Crohn’s disease – A systematic review
- 13 July 2020
- Published by S. Karger AG in Complementary Medicine Research
- Vol. 28 (1) , 15-22
Anticancer Effects of Viscum album Fraxini Extract on Medulloblastoma Cells in vitro
Background: Mistletoe therapy is frequently administered as a supportive treatment in diverse pediatric cancer entities including brain tumors. Medulloblastoma is the most common brain tumor in childhood. Its high risk to metastasize and its long-term sequelae caused by aggressive chemo- or radiotherapies are still challenging. Material and Methods: Effects of a lectin-rich mistletoe extract, abnobaVISCUM Fraxini, were investigated in two medulloblastoma cell lines (Daoy and ONS-76). Responsiveness of tumor cells was assessed by cell viability assays and xCELLigence real-time analyses. Moreover, impacts on proliferation, cell cycle and apoptosis were investigated. Apoptosis was studied by staining of vital mitochondria and assessing the involvement of caspases. In addition, effects on migration and invasion were analyzed. Results: Both medulloblastoma cell lines were more susceptible to treatment with the mistletoe extract than a nontumorigenic fibroblast cell line. In mistletoe-sensitive Daoy cells, reduction of proliferation and induction of caspase-mediated apoptosis were observed upon administration of 0.05 and 0.5 mg/mL abnobaVISCUM Fraxini treatment, respectively. Furthermore, mistletoe extract inhibited migration and invasion properties in Daoy and significantly impaired invasive capabilities of ONS-76 cells. Conclusion: AbnobaVISCUM Fraxini has cell line dependent antitumoral effects in medulloblastoma models. These results call for further investigations, to reveal mechanistic insights into antitumorigenic properties of mistletoe extracts.
- 13 July 2020
- Published by S. Karger AG in Complementary Medicine Research
- Vol. 28 (1) , 15-22
Anticancer Effects of Viscum album Fraxini Extract on Medulloblastoma Cells in vitro
Background: Mistletoe therapy is frequently administered as a supportive treatment in diverse pediatric cancer entities including brain tumors. Medulloblastoma is the most common brain tumor in childhood. Its high risk to metastasize and its long-term sequelae caused by aggressive chemo- or radiotherapies are still challenging. Material and Methods: Effects of a lectin-rich mistletoe extract, abnobaVISCUM Fraxini, were investigated in two medulloblastoma cell lines (Daoy and ONS-76). Responsiveness of tumor cells was assessed by cell viability assays and xCELLigence real-time analyses. Moreover, impacts on proliferation, cell cycle and apoptosis were investigated. Apoptosis was studied by staining of vital mitochondria and assessing the involvement of caspases. In addition, effects on migration and invasion were analyzed. Results: Both medulloblastoma cell lines were more susceptible to treatment with the mistletoe extract than a nontumorigenic fibroblast cell line. In mistletoe-sensitive Daoy cells, reduction of proliferation and induction of caspase-mediated apoptosis were observed upon administration of 0.05 and 0.5 mg/mL abnobaVISCUM Fraxini treatment, respectively. Furthermore, mistletoe extract inhibited migration and invasion properties in Daoy and significantly impaired invasive capabilities of ONS-76 cells. Conclusion: AbnobaVISCUM Fraxini has cell line dependent antitumoral effects in medulloblastoma models. These results call for further investigations, to reveal mechanistic insights into antitumorigenic properties of mistletoe extracts.
- 16 June 2020
- Published by Georg Thieme Verlag KG in Erfahrungsheilkunde
- Vol. 69 (03) , 177-180
Verbrennungen und Verbrühungen: Wundversorgung bei Kindern
Zusammenfassung: Bei Kindern steht die Häufigkeit von Brandverletzungen an dritter Stelle der Unfallursachen. Dabei sind mehr als 70 % dieser thermischen Verletzungen auf Schädigung durch Verbrühung zurückzuführen. Sind die betroffenen Hautareale eher klein und übersteigt die Verbrennungstiefe nicht den zweiten Grad, so können diese Verletzungen meist noch ambulant versorgt werden. Hier stehen die Vermeidung einer Wundinfektion und das schnelle und narbenfreie Abheilen der verletzten Haut im Vordergrund. Um dieses Behandlungsziel zu erreichen, entwickelten Ärzte der Abteilung für Kinder- und Jugendmedizin des Gemeinschaftskrankenhauses Herdecke ein Therapiekonzept unter Einsatz anthroposophischer Arzneimittel, mit denen im Praxisalltag sehr gute Ergebnisse erzielt werden können. Im Folgenden wird dieses etablierte Therapiekonzept auf Basis der klinischen Erfahrungen aus dem Alltag vorgestellt und die wundheilungsfördernden pflanzlichen Bestandteile der verwendeten Arzneimittel werden erläutert.
- 16 June 2020
- Published by Georg Thieme Verlag KG in Erfahrungsheilkunde
- Vol. 69 (03) , 177-180
Verbrennungen und Verbrühungen: Wundversorgung bei Kindern
Zusammenfassung: Bei Kindern steht die Häufigkeit von Brandverletzungen an dritter Stelle der Unfallursachen. Dabei sind mehr als 70 % dieser thermischen Verletzungen auf Schädigung durch Verbrühung zurückzuführen. Sind die betroffenen Hautareale eher klein und übersteigt die Verbrennungstiefe nicht den zweiten Grad, so können diese Verletzungen meist noch ambulant versorgt werden. Hier stehen die Vermeidung einer Wundinfektion und das schnelle und narbenfreie Abheilen der verletzten Haut im Vordergrund. Um dieses Behandlungsziel zu erreichen, entwickelten Ärzte der Abteilung für Kinder- und Jugendmedizin des Gemeinschaftskrankenhauses Herdecke ein Therapiekonzept unter Einsatz anthroposophischer Arzneimittel, mit denen im Praxisalltag sehr gute Ergebnisse erzielt werden können. Im Folgenden wird dieses etablierte Therapiekonzept auf Basis der klinischen Erfahrungen aus dem Alltag vorgestellt und die wundheilungsfördernden pflanzlichen Bestandteile der verwendeten Arzneimittel werden erläutert.
- Open Access
- 3 December 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-9
Do patients of integrative anthroposophic pediatric inpatient departments differ? Comparative analysis to all pediatric inpatients in Germany considering demographic and clinical characteristics
Background: Integrative medicine (IM) is a patient-centered, evidence-based, therapeutic paradigm which combines conventional and complementary approaches. The use of IM in pediatrics has increased in the past two decades and parents’ demand for it is growing. An IM whole systems approach is anthroposophic medicine. Considering the growing demand for integrative approaches in children, it is relevant from a public health perspective to find out which kind of children use IM in Germany and whether they differ from the entirety of pediatric inpatients in Germany. Moreover, it would be interesting to known, whether these patients are willing to travel a longer distance to gain integrative treatment.Methods: The present study investigates the standard ward documentation datasets of 29,956 patients of all German integrative anthroposophic pediatric inpatient wards from 2005 to 2016 and compares them systematically to collect data of the entirety of all pediatric inpatient wards in Germany. Apart from patients’ age and gender, and the ICD-10 admission diagnoses, the geographical catchment area of the hospitals were analyzed.Results: Sociodemographic characteristics of pediatric inpatients in the integrative anthroposophic departments (IAH) did not differ from the entirety of all pediatric inpatients. Regarding clinical characteristics, higher frequencies were found for endocrine, nutritional and metabolic diseases (IAH: 7.24% vs. 2.98%); mental, behavioral, and neurodevelopmental disorders (IAH: 9.83% vs. 3.78%) and nervous diseases (IAH: 8.82% vs. 5.16%) and lower frequencies for general pediatric diseases such as respiratory diseases (IAH: 17.06% vs. 19.83%), digestive diseases (IAH: 3.90% vs. 6.25%), and infectious and parasitic diseases (IAH: 12.88% vs. 14.82%) in comparison to the entirety of all pediatric inpatients in Germany. The IAH showed a broad catchment area, with most patients being from former, Western federal republic of Germany. Large catchment areas (> 100 km) for the IAH are merely covered by severe and chronic diseases.Conclusion: Pediatric inpatients of IAH do not differ from the entirety of pediatric inpatients in Germany regarding sociodemographic characteristics but show differences regarding clinical characteristics. Parents are willing to travel further distance to get specialized integrative anthroposophic medical care for children with severe and chronic diseases.
- 3 December 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-9
Open AccessDo patients of integrative anthroposophic pediatric inpatient departments differ? Comparative analysis to all pediatric inpatients in Germany considering demographic and clinical characteristics
Background: Integrative medicine (IM) is a patient-centered, evidence-based, therapeutic paradigm which combines conventional and complementary approaches. The use of IM in pediatrics has increased in the past two decades and parents’ demand for it is growing. An IM whole systems approach is anthroposophic medicine. Considering the growing demand for integrative approaches in children, it is relevant from a public health perspective to find out which kind of children use IM in Germany and whether they differ from the entirety of pediatric inpatients in Germany. Moreover, it would be interesting to known, whether these patients are willing to travel a longer distance to gain integrative treatment.Methods: The present study investigates the standard ward documentation datasets of 29,956 patients of all German integrative anthroposophic pediatric inpatient wards from 2005 to 2016 and compares them systematically to collect data of the entirety of all pediatric inpatient wards in Germany. Apart from patients’ age and gender, and the ICD-10 admission diagnoses, the geographical catchment area of the hospitals were analyzed.Results: Sociodemographic characteristics of pediatric inpatients in the integrative anthroposophic departments (IAH) did not differ from the entirety of all pediatric inpatients. Regarding clinical characteristics, higher frequencies were found for endocrine, nutritional and metabolic diseases (IAH: 7.24% vs. 2.98%); mental, behavioral, and neurodevelopmental disorders (IAH: 9.83% vs. 3.78%) and nervous diseases (IAH: 8.82% vs. 5.16%) and lower frequencies for general pediatric diseases such as respiratory diseases (IAH: 17.06% vs. 19.83%), digestive diseases (IAH: 3.90% vs. 6.25%), and infectious and parasitic diseases (IAH: 12.88% vs. 14.82%) in comparison to the entirety of all pediatric inpatients in Germany. The IAH showed a broad catchment area, with most patients being from former, Western federal republic of Germany. Large catchment areas (> 100 km) for the IAH are merely covered by severe and chronic diseases.Conclusion: Pediatric inpatients of IAH do not differ from the entirety of pediatric inpatients in Germany regarding sociodemographic characteristics but show differences regarding clinical characteristics. Parents are willing to travel further distance to get specialized integrative anthroposophic medical care for children with severe and chronic diseases.
- 6 November 2019
- Published by Elsevier in Phytomedicine
- Vol. 61, 4
Preclinical investigation of interaction of mistletoe extract (Viscum album L.) with radio- and chemotherapy in pediatric tumor cell lines
- 6 November 2019
- Published by Elsevier in Phytomedicine
- Vol. 61, 4
Preclinical investigation of interaction of mistletoe extract (Viscum album L.) with radio- and chemotherapy in pediatric tumor cell lines
- 19 October 2019
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 49, 102217
Complementary and alternative medicine in the treatment of acute bronchitis in children: A systematic review
- 19 October 2019
- Published by Elsevier in Complementary Therapies in Medicine
- Vol. 49, 102217
Complementary and alternative medicine in the treatment of acute bronchitis in children: A systematic review